ArticlePharmaceutics2019

Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis.

Diana Berenguer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.